Prevention news, opinions and education

heartwire News

  • Marijuana Edible Linked to Myocardial Infarction Legalization of marijuana has led to higher use, including among the elderly and cardiac patients. A new case report highlights risks and points to the need for more research and patient education.
  • Insurance Doesn't Ensure Against Financial Hardship in ASCVD Even those with insurance feel financial hardship because of high premiums, deductibles, copays, and coinsurance. The report adds fuel to the push to lower the Medicare buy-in age to 50.
  • Syncope Monitoring in ED: 2 Hours Okay for Low-Risk Patients Patients with syncope who present to the emergency department and who are at low risk for serious arrhythmia can be discharged home after 2 hours of electrocardiogram monitoring, new data show.
  • Second Price Cut for PCSK9 Inhibitor Alirocumab (Praluent) The move brings the price down about 60% from the original cost of the cholesterol-lowering drug and brings alirocumab in line with the cost of its competitor PCSK9 inhibitor, evolocumab.


  • Cardiology Topics to Watch for in 2019 Wearables, aspirin for secondary prevention, AI and machine learning, and drug pricing are among the topics to keep an eye on in 2019, according to cardiologists Drs Harrington and Gibson.
  • Supplements and CVD: Why Negative Data Don't Dampen Sales Dietary supplements are a $133 billion industry globally, despite a lack of supportive data. Should healthcare providers do more to dissuade patients who persist in taking these pricey placebos?
  • Choosing a First Injectable in Type 2 Diabetes: Try a GLP-1   The new ADA/EASD guidelines suggest major changes in the way we manage patients with T2D. Drs Shubrook and Skolnik focus on new information about the GLP-1 receptor agonists, why to use them, and how to choose which to use.
  • What's New in the 2019 Standards of Medical Care in Diabetes   From telemedicine to patient education and lifestyle management, Dr Peters highlights key changes to this year's ADA standards for diabetes care.